Co-op: Computational Chemistry for Chiral Ligand Design

Alexion Pharmaceuticals, Inc. seeks a motivated PhD candidate for a 6-month co-op in 1H 2027 to advance data-driven catalyst design within the SPD team.

The role builds a closed-loop platform combining DFT, ML, and Bayesian optimization to accelerate chiral ligand development, followed by experimental validation and knowledge transfer across the team. This hands-on project spans translational research and early development.